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Foreword
The National Institute for Occupational Safety and Health (NIOSH) is pleased to present Pro-
tecting the Nanotechnology Workforce: NIOSH Nanotechnology Research and Guidance Strategic Plan, 
2013–2016. This plan updates the November 2009 strategic plan with knowledge gained from 
results of ongoing research, as described in the 2012 report Filling the Knowledge Gaps for Safe 
Nanotechnology in the Workplace: A Progress Report from the NIOSH Nanotechnology Research Center, 
2004–2011. The NIOSH Nanotechnology Research Program follows a comprehensive plan that is 
managed as a matrix structure across NIOSH and supports multiple sectors in the National Occu-
pational Research Agenda (NORA). 
Nanotechnology provides many opportunities for advancing the economic value and impact of new 
U.S. technologies and products as it expands into every industrial sector. Today, nanomaterials are 
found in hundreds of products, ranging from cosmetics, to clothing, to industrial and biomedical 
applications. The potential benefits of nanotechnology are huge, and these benefits should be re-
alized by society. However, there is ongoing concern that the full potential of the societal benefits 
may not be realized if research efforts are not undertaken to determine how to best manage and 
control the potential occupational safety and health hazards associated with the handling of these 
nanomaterials. 
The research conducted over the past 8 years has proven that NIOSH is a global leader in promot-
ing the responsible development of nanotechnology. NIOSH has built business partnerships, estab-
lished itself as a key player in nanotoxicology, published precautionary guidance (Approaches to Safe 
Nanotechnology: Managing the Safety and Health Concerns Associated with Engineered Nanomaterials), 
and issued recommended exposure limits for nanoscale titanium dioxide and for carbon nanotubes 
and nanofibers. 
This NIOSH Nanotechnology Research and Guidance Strategic Plan is the roadmap being used to ad-
vance basic understanding of the toxicology and workplace exposures involved so that appropriate 
risk management practices can be implemented during discovery, development, and commercializa-
tion of engineered nanomaterials. NIOSH will strive to remain at the forefront of developing guid-
ance that supports and promotes the safe and responsible development of such a promising tech-
nology.
John Howard, M.D.
Director, National Institute for Occupational 
Safety and Health
Centers for Disease Control and Prevention
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Executive Summary
Nanotechnology—the manipulation of matter on a near-atomic scale to produce new materials 
and devices—has the ability to transform many industries, from medicine to manufacturing, and 
the products they produce. By 2020, the National Science Foundation estimates, nanotechnology 
will have a $3 trillion impact on the global economy and employ 6 million workers in the manufac-
ture of nanomaterial-based products, of which 2 million may be manufactured in the United States 
[NSF 2011]. Nanomaterials may present new challenges to understanding, predicting, and manag-
ing potential health risks to workers. 
Many knowledge gaps still remain on how to work safely with all of these materials. Through stra-
tegic planning, research, partnering with stakeholders, and making information widely available, the 
National Institute for Occupational Safety and Health (NIOSH) is working to continue to provide 
national and world leadership in providing solutions that will prevent work-related illness and injury.
Nanotechnology and NIOSH Research
Nanotechnology and the commercialization of products and devices containing engineered nano-
materials could help address critical global problems concerning energy, transportation, pollution, 
health, and food. The potential benefits of nanotechnology are huge, and these benefits should be 
realized. Nonetheless, there is concern that the full potential of the societal benefits may not be re-
alized if cautions about the adverse human health effects are not heeded and concerns are not hon-
ored. Timely, targeted research is needed to define hazards, exposures, and risks and to provide 
guidance for safe handling of nanomaterials. A concerted effort by industry, academia, labor, the 
professions, and government is needed to identify and address the knowledge gaps in a transpar-
ent and credible process that coincides with development of this new technology. NIOSH is play-
ing an active part in this process by supporting the development of a broad spectrum of research 
and prevention strategies for health and safety hazards related to nanotechnology. In a series of re-
ports [NIOSH 2007, 2009a, 2012a], NIOSH has summarized its progress in conducting nano-
technology research and recommending risk management strategies (see http://www.cdc.gov/niosh/
topics/nanotech/). NIOSH investigators have identified adverse health effects in animals exposed to 
various engineered nanomaterials; assessed exposure of workers; initiated epidemiologic research; 
and provided guidance on control technologies and medical surveillance. There are many questions 
still to be answered. A vast number of potential new nanomaterials are possible and could result in 
a seemingly limitless combination of physicochemical factors. There is need for an expeditious ap-
proach to controlling exposure to the large number of nanomaterials in science and commerce now 
and in the future. Moreover, the advanced nanomaterials under development are likely to have ad-
ditional potentially hazardous characteristics that will need to be addressed [Murashov et al. 2012]. 
NIOSH Nanotechnology Research Center (NTRC)
The NIOSH Nanotechnology Research Center (NTRC) was established in 2004 to coordinate 
nanotechnology research across the institute. Ten critical areas of research were identified, each hav-
ing at least one key scientist serving as a coordinator. The NTRC and its steering committee of crit-
ical area coordinators are responsible for developing and guiding NIOSH scientific and organiza-
tional plans in nanotechnology health and safety research. 
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Strategic Plan
The development of nanotechnology has reached a point where it is being widely applied, and nu-
merous nanomaterials and nano-enabled products are in commerce. Nanotechnology has the po-
tential to provide great benefit to society, but it must be developed responsibly. This responsibili-
ty involves addressing any adverse human and environmental impacts of the technology associated 
with engineered nanomaterials (ENMs). Workers are among the first people in any society to be 
exposed to the potential health hazards caused by the products of new technology, and their expo-
sure to any new material is often greater than for the general population. Therefore, worker safety 
and health can be seen as the core of responsible development (Figure 1).
Through its strategic plan for fiscal years (FY) 2013–2016, NIOSH will marshal its resources and 
partner with others efficiently and effectively to advance efforts to protect the nanotechnology 
workforce. With the input of a broad range of stakeholders in government, academia, and the pri-
vate sector, NIOSH will continue to operate under a strategic plan for nanotechnology research and 
guidance. The most recent previous version was published in November 2009 and included research 
plans through FY 2012 (see http://www.cdc.gov/niosh/docs/2010-105/).  
Figure 1. The core of responsible development of nanotechnology.
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This document presents the NTRC Strategic Plan for FY2013–FY2016. The strategic plan also 
highlights how the critical research and guidance efforts of NIOSH align with and support the 
comprehensive Environmental, Health, and Safety Research Strategy needs of the National Nan-
otechnology Initiative. For the period FY2013–FY2016, NIOSH will continue to fill information 
and knowledge gaps that address the five NIOSH NTRC strategic goals:
1. Increase understanding of new hazards and related health risks to nanomaterial workers.
2. Expand understanding of the initial hazard findings of engineered nanomaterials.
3. Support the creation of guidance materials to inform nanomaterial workers, employers, 
health professionals, regulatory agencies, and decision-makers about hazards, risks, and risk 
management approaches.
4. Support epidemiologic studies for nanomaterial workers, including medical, cross-sectional, 
prospective cohort, and exposure studies. 
5. Assess and promote national and international adherence with risk management guidance. 
To address these strategic goals and promote the responsible development of engineered nanoma-
terials, the strategic plan will expand research activities in 10 NTRC critical areas: toxicity and in-
ternal dose; measurement methods; exposure assessment; epidemiology and surveillance; risk as-
sessment; engineering controls and personal protective equipment (PPE); fire and explosion safety; 
recommendations and guidance; global collaborations; and applications. 
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1 INTRODUCTION
1.1 Background
Nanotechnology is a system of innovative meth-
ods to control and manipulate matter at near-
atomic scale to produce new materials, structures, 
and devices. Nano-objects are nanomaterials that 
have at least one dimension less than 100 nano-
meters [ISO 2008]. Nanoparticles are a specific 
class or subset of these nano-objects, having three 
dimensions that are less than 100 nanometers. 
Nanoparticles exhibit unique properties because 
of their nanoscale dimensions. Nanotechnolo-
gy offers the potential for tremendous improve-
ment and advances in the development of com-
mercial products that may benefit society, such 
as integrated sensors, semiconductors, medical 
imaging, drug delivery systems, structural mate-
rials, sunscreens, cosmetics, and coatings. Nano-
technology is one of the most enabling technolo-
gies across the world. By 2020, the global market 
for nanotechnology-related products is predicted 
to reach $3 trillion and employ 2 million work-
ers in the United States alone [NSF 2011]. A 
review of the 2013 version of the Nanowerk 
nanomaterials database (http://www.nanowerk.
com/phpscripts/n_dbsearch.php) revealed more than 
3,000 commercially available nanomaterials. 
However, the properties of engineered nanopar-
ticles (e.g., size, surface area, reactivity) that yield 
many improvements in commercial products 
may also pose health risks. Increasing numbers 
of workers are potentially exposed to nanoma-
terials in research laboratories, start-up compa-
nies, production facilities, and operations where 
nanomaterials are processed, used, disposed, or 
recycled. The challenge is to determine wheth-
er the nature of intentionally produced (engi-
neered) nanostructured materials and devic-
es presents new occupational safety and health 
risks. At the same time, there is a need to ad-
dress how the benefits of nanotechnology can 
be realized while the risks are proactively min-
imized. 
Efforts across multiple federal agencies and the 
private and academic sectors are fostering the 
development and use of nanotechnology. In 
2001, the President’s Council of Advisors on 
Science and Technology collaborated with the 
interagency National Science and Technology 
Council to create the National Nanotechnol-
ogy Initiative (NNI) [NNI 2001]. This initia-
tive supports basic and applied research in nan-
otechnology to create new nanomaterials and to 
disseminate new technical capabilities to indus-
try. The purpose of the NNI is to facilitate sci-
entific breakthroughs and maintain U.S. com-
petitiveness in nanoscience. A stated goal of this 
interagency program is to ensure that nanotech-
nology research leads to the responsible devel-
opment of beneficial applications by giving high 
priority to research on human health, environ-
mental issues, and societal implications related 
to nanotechnology. 
1.2 Mission of NIOSH
In the Occupational Safety and Health Act of 
1970 (OSH Act, Public Law 91-596) and the 
Federal Mine Safety and Health Act of 1977 
(FMSH Act, Public Law 95-164), Congress de-
clared that the intent of these acts was to ensure, 
insofar as possible, safe and healthful working 
conditions for every working man and woman, 
to preserve our human resources. In these acts, 
NIOSH is given the responsibility for recom-
mending occupational safety and health stan-
dards and defining exposure levels that are safe 
for various periods of employment. These in-
clude (but are not limited to) the exposures at 
which no worker will suffer diminished health, 
functional capacity, or life expectancy as a result 
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of his or her work experience. By means of crite-
ria documents and other publications, NIOSH 
communicates these recommended standards 
to the Occupational Safety and Health Admin-
istration (OSHA), the Mine Safety and Health 
Administration (MSHA), and others in the oc-
cupational safety and health community. 
Under the OSH Act, NIOSH is charged with 
conducting “research, experiments, and dem-
onstrations relating to occupational safety and 
health” and with developing “innovative meth-
ods, techniques, and approaches for dealing 
with [those] problems.” The act specifies target 
areas of research that include identifying crite-
ria for setting worker exposure standards and 
exploring problems created by new technology 
in the workplace. In an amendment to the act, 
NIOSH was given responsibility for conduct-
ing training and education “to provide an ade-
quate supply of qualified personnel to carry out 
the purposes of the Act” and for assisting em-
ployers and workers with applying methods to 
prevent occupational injuries and illness (Sec-
tion 21 of the OSH Act).
NIOSH has over 40 years of experience in con-
ducting research and formulating recommen-
dations for occupational safety and health. 
During this period, NIOSH has developed 
considerable expertise in measuring, character-
izing, and evaluating new processes and new 
materials by conducting quantitative expo-
sure assessments and evaluating health effects. 
NIOSH also has expertise in developing expo-
sure control systems and prevention strategies 
as well as experience in conducting risk assess-
ments and recommending effective risk man-
agement practices.
In 2003, NIOSH became a member of the Na-
noscale Science, Engineering, and Technology 
(NSET) Subcommittee of the National Sci-
ence and Technology Council. As a member, 
NIOSH participates in (1) identifying critical 
issues related to possible hazards of nanoma-
terials, (2) protecting worker safety and health 
in this emerging technology, and (3) developing 
a strategic plan to address such issues and 
recommend prevention strategies for the safe 
handling and use of nanomaterials. 
In 2004, NIOSH created the Nanotechnology 
Research Center (NTRC) to identify critical 
issues, create a strategic plan for investigating 
these issues, coordinate the NIOSH research 
effort, develop research partnerships, and dis-
seminate information gained. The NTRC com-
prises nanotechnology-related activities and 
projects supported by approximately 50 sci-
entists in various NIOSH divisions and lab-
oratories. Through the NTRC, NIOSH has 
identified 10 critical research areas for nano-
technology research and communication. These 
10 critical research areas, updated for FY2013–
FY2016, are toxicity and internal dose; mea-
surement methods; exposure assessment; ep-
idemiology and surveillance; risk assessment; 
engineering controls and personal protec-
tive equipment (PPE); fire and explosion safe-
ty; recommendations and guidance; global col-
laborations; and applications. By conducting a 
complete plan of research in these critical areas 
in a coordinated, concurrent manner, NIOSH 
is comprehensively addressing the information 
and knowledge gaps necessary to protect work-
ers and responsibly move nanotechnology for-
ward so that its far-reaching benefits may be re-
alized. 
The NIOSH NTRC is working strategical-
ly to fill nanomaterial occupational safety and 
health knowledge gaps through active intra-
mural and extramural research programs and 
collaborations. Extramural research is carried 
out through the NIOSH Office of Extramu-
ral Programs (OEP), in which nanotechnolo-
gy research (through R01, K01, R03, R21, and 
R43/44 grant mechanisms) is funded to in-
crease the knowledge of nanotechnology and 
engineered nanomaterials (ENMs) as they re-
late to occupational safety and health. Research 
areas supported by the NIOSH OEP include 
emission and exposure assessment methods 
for nanoparticles in the workplace, toxicology 
of ENMs, and use of nanotechnology for the 
development of sensors. NIOSH is committed 
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to conducting and supporting studies that will 
improve scientists’ abilities to identify potential 
occupational health effects of nanomaterials. 
NIOSH will facilitate the translation of those 
findings into effective workplace practices. 
NIOSH reported on the progress of the NTRC 
in Filling the Knowledge Gaps for Safe Nano-
technology in the Workplace (Figure 2). This re-
port presents the program accomplishments of 
the NTRC from its inception in 2004 through 
2011.  
The NIOSH NTRC continues to be part of the 
U.S. leadership on the International Organiza-
tion for Standardization (ISO) TC 229 Nano-
technology Working Group on Health, Safe-
ty, and the Environment and continues to work 
with the World Health Organization (WHO) 
collaborating centers on global projects of in-
formation dissemination and communication. 
Through these collaborations, the NIOSH 
NTRC assists in developing risk communica-
tions on the safe handling of nanomaterials.
1.3 NIOSH Logic Model
NIOSH receives input on identifying and ad-
dressing occupational safety and health prob-
lems through a logic model (i.e., a process) in 
which the seriousness of the problem or haz-
ard is evaluated, the type and level of research 
needed are determined, and a plan and process 
for communicating the research outcomes are 
formulated. The overall NIOSH logic model 
(Figure 3) has a conventional horseshoe shape, 
with the operational upper branch proceeding 
from inputs to mission relevant outcomes and 
the strategic lower branch supporting those op-
erations through a process of measurable goals 
and management objectives. The two branches 
are correlated and are subject to external factors.  
The NIOSH operational model (Figure 4) for 
conducting research adheres to the logic mod-
el in the acquisition and analysis of inputs from 
customers/stakeholders (production inputs) and 
internal/external research capabilities (planning 
inputs) to determine and prioritize research. 
Figure 2. The cover of DHHS (NIOSH) Publication No. 2013–101, the progress report of the NTRC.
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Intramural and extramural researchers present 
their project proposals, which receive appropri-
ate internal and external review and are funded 
on the basis of merit. The conduct of research 
(activities) produces “outputs” such as guid-
ance documents and reports that address ef-
fective risk management practices, worker and 
employer education, and new technologies for 
assessing and controlling workplace hazards. 
NIOSH outputs are transferred directly to the 
final customers and stakeholders (who imple-
ment improvements in workplace safety and 
health) or to intermediate customers (who uti-
lize NIOSH outputs to produce intermediate 
outcomes). These intermediate outcomes, such 
Figure 3. Schematic of the overall NIOSH logic model. 
as training programs, regulations, and occupa-
tional standards, are used to advance workplace 
safety and health. Since NIOSH is not a regu-
latory agency, it relies heavily on efforts by in-
termediate and final customers to achieve ulti-
mate outcomes in the form of workplace safety 
and health improvements. The effectiveness in 
achieving these outcomes is influenced at all 
stages of the program operation by both exter-
nal factors (such as economic and social con-
ditions) and the regulatory environment. Re-
sults of NIOSH-funded research and customer 
feedback (intermediate and final outcomes) con-
tribute to the subsequent rounds of program 
planning. 
Inputs Activities Outputs Customers
Management
Objectives
Annual
Goals
External factors
Intermediate
Goals
Strategic
Goals
Outcomes
Operations
Strategy and design
Mission
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2 INPUTS
2.1 Nature of Nanomaterials
The universe of nanomaterials is potentially 
large because of the array of possible combina-
tions of physicochemical parameters, impurities, 
and manufacturing and production conditions 
(Figure 5). NIOSH recognizes the extensive di-
versity and number of nanomaterials and the 
even larger number of applications for those 
materials. Consequently, it continues to use ap-
proaches that allow for a holistic view of nano-
materials and development of priorities that will 
be beneficial to many workers.
2.2 Nature of the 
Nanomaterial Workplace
Worker exposure to nanomaterials may occur 
along the life cycle of the nanomaterial, from re-
search through scale-up, manufacturing, prod-
uct development, use, and end of life (Figure 6). 
Each of the functional areas represents work-
places with different potential exposure scenar-
ios and risks. NIOSH continues to focus on 
the wide array of workplaces where exposure to 
nanomaterials may occur.  
2.3 Customer and 
Stakeholder Input
To direct its research and fulfill its responsi-
bilities under the OSH Act and the FMSH 
Act, NIOSH has relied on input from OSHA 
and MSHA, workers, employers, trade associ-
ations, unions, occupational safety and health 
practitioners and researchers, and the general 
public. NIOSH also seeks input through for-
mal committees, such as the NIOSH Board 
of Scientific Counselors, the National Advi-
sory Committee on Occupational Safety and 
Health, and the Mine Safety and Health Re-
search Advisory Committee. It also receives 
Figure 5. The wide variety of physicochemical parameters of engineered nanomaterials [Schulte et al. 2009].
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Figure 6. The life cycle of nanomaterials [Schulte et al. 2008a].
Research Laboratories
Start-Up/Scale-Up Operations
Manufacturing/Production
Incorporation in Products
Recycling
Warehousing/Maintenance
Waste Handling
Transport
Warehousing/Maintenace
Warehousing/Maintenance
Transport
Waste handling
Maintenance of Products
Manipulation of Products
Application of Products-Medical Delivery
Disposal/End of Life
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input through ad hoc mechanisms such as the 
NIOSH Web site (www.cdc.gov/niosh), a toll-
free telephone line (1-800-CDC-INFO), per-
sonal contacts with occupational safety and 
health professionals, and participation in pro-
fessional conferences and interagency commit-
tees. In addition, NIOSH provides stewardship 
of the National Occupational Research Agenda 
(NORA) (http://www.cdc.gov/niosh/nora), which 
is a framework to guide occupational safety and 
health research into the new millennium—not 
only for NIOSH but for the entire occupation-
al safety and health community.
NIOSH continues to be a participating and 
partnering agency in the National Nanotech-
nology Initiative (NNI) and provides occu-
pational health and safety expertise in sup-
port of the U.S. Government’s Strategic Plan 
for Nanotechnology Environmental, Health, 
and Safety Research [NNI 2011]. NIOSH is 
co-leader of the NNI Nanotechnology En-
vironmental and Health Implications Work-
ing Group (NEHI) and contributed to the de-
velopment of the 2011 NEHI Environmental, 
Health, and Safety (EHS) Research Strategy. 
The 2011 NEHI EHS research strategy iden-
tified five core nanotechnology EHS research 
categories: (1) nanomaterial measurement in-
frastructure, (2) human exposure assessment, (3) 
human health, (4) environment, and (5) risk as-
sessment and management methods (Appendix 
A) [NNI 2011]. NIOSH provided significant 
input for the strategy and was the lead agen-
cy for developing recommendations on human 
exposure assessment. The NNI EHS research 
strategy focuses on the use of science-based risk 
analysis and risk management to protect public 
health and the environment while fostering the 
technological advancements that benefit soci-
ety. NIOSH has strived to keep the overarching 
research activities of the NTRC nanotechnol-
ogy strategic plan (Section 4.3) consistent with 
the NNI EHS research strategy.
The NIOSH NTRC also fosters stakeholder in-
put with trade associations, professional associ-
ations, labor, nongovernmental organizations, 
and a number of private nanomaterial compa-
nies. These collaborations have provided exper-
tise and resources critical for reviewing research 
activities and for developing and disseminating 
health and safety information on engineered 
nanoparticles. Some of the ongoing NTRC 
stakeholders are the American Industrial Hy-
giene Association (AIHA), American Soci-
ety of Safety Engineers (ASSE), International 
Safety Equipment Association (ISEA), Na-
tional Safety Council (NSC), American Feder-
ation of Labor and Congress of Industrial Or-
ganizations (AFL–CIO), and NanoBusiness 
Commercialization Association (NanoBCA).
2.4 NIOSH Research Capabilities
Within its divisions, NIOSH has world-re-
nowned researchers who are trained and expe-
rienced in the full spectrum of scientific skills 
needed to evaluate and characterize workplace 
hazards and devise intervention strategies for 
protecting workers. In addition to this exper-
tise, NIOSH has significant laboratory capa-
bilities in particle measurement, aerosol col-
lection and characterization, particle surface 
analysis, measurement of particle surface rad-
icals and activity, and in vitro and in vivo anal-
ysis of toxicity and pathogenesis. Laboratories 
conducting nanomaterial research are locat-
ed in Cincinnati, Ohio; Pittsburgh, Pennsylva-
nia; and Morgantown, West Virginia. NIOSH 
researchers work closely with a broad range of 
scientists from industry, academia, and oth-
er government agencies. The involvement of 
NIOSH in national and international initia-
tives and programs is an important component 
of its capacity to address critical occupational 
safety and health issues in nanotechnology.
2.5 NIOSH Partnerships 
NIOSH recognizes both the practical need and 
the leadership obligation to extend its internal 
capabilities by leveraging activities and expertise 
found in other research institutions, industries, 
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federal agencies, and nongovernmental organi-
zations. These partnerships serve to deliver on 
multiple objectives; most important, they add 
to the body of knowledge on workplace health 
and safety issues associated with nanotechnolo-
gy. Partnerships have taken several forms, rang-
ing from formal letters or memoranda of un-
derstanding to informal working agreements 
on a specific topic. NIOSH will continue to 
pursue partnerships as a means of achieving the 
goals of this strategic research plan and as ef-
fective vehicles to develop and disseminate re-
search results.
The NIOSH NTRC has successfully used part-
nerships with industry to gain a better under-
standing of actual industrial nanomaterial pro-
cesses, workplace exposures, work practices, and 
exposure control techniques. The field research 
conducted by the NTRC to assess exposures to 
engineered nanoparticles represents ongoing part-
nerships with numerous companies. The NTRC 
will continue to develop these partnerships to 
 • better understand how engineered 
nanoparticles are being produced and used
 • develop recommendations for the safe 
handling of nanomaterials
 • develop sampling and analytical methods
 • evaluate exposure controls that are or 
could be used in nanomaterial processes
 • evaluate the need for and determine the 
effectiveness of PPE, including respira-
tory protection
 • develop communication and informa-
tion materials that will assist industry in 
communicating with workers and the 
public. 
Several of the industrial partnerships have pro-
vided opportunities for the NTRC to identi-
fy areas in which additional research is needed. 
The continued collaboration with other na-
tional and international research institutes, ac-
ademia, and government agencies provides the 
NTRC the opportunity to combine its exper-
tise in workplace health and safety with the 
capabilities of other organizations to investi-
gate specific areas of concern. Working rela-
tionships with other research institutes pro-
vide the NTRC with the information needed 
to guide its own research, focus its limited re-
sources effectively, and expand its research ca-
pabilities through scientific collaboration. The 
NTRC has developed partnerships in the ar-
eas of toxicology, risk assessment modeling, ex-
posure measurement methods, epidemiology, 
industrial hygiene, control technologies, filtra-
tion of nanoparticles, and communication of 
research results and safe work practices. 
The NTRC has broadened its activities with 
collaborators and stakeholders by participating 
in a number of national and international com-
mittees and working groups. This participation 
provides NTRC scientists the opportunity to 
provide and receive input on the key research 
that is needed to address priority areas. 
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3 ACTIVITIES
3.1 NIOSH Nanotechnology 
Research Center (NTRC)
Vision of the NTRC
The vision of the NTRC is as follows:
Safe nanotechnology by delivering on the Na-
tion’s promise—safety and health at work for all 
people through research and prevention. 
Mission of the NTRC
The mission of the NTRC is to provide nation-
al and world leadership for research and guid-
ance on the implications of nanoparticles and 
nanomaterials for work-related injury and ill-
ness, and the application of nanoparticles and 
nanomaterials in occupational safety and health.
3.2 NTRC Steering Committee
The NTRC Steering Committee is chaired by 
the NTRC Coordinator. The committee is made 
up of the program manager, program coordina-
tor, program assistant coordinator, and critical 
area coordinators for each of the 10 research areas 
(some areas have multiple research coordinators). 
The steering committee is responsible for guid-
ing NIOSH scientific and organizational plans 
in nanotechnology research (including coordina-
tion for science and budget) and for developing 
strategic goals and objectives and performance 
measures for the NTRC. Regular updates and 
progress reports on internal research activities 
are managed through biweekly teleconferences 
among members of the NTRC Steering Com-
mittee. In addition, to ensure the responsiveness, 
relevance, and impact of the NIOSH nanotech-
nology program, members of the NTRC and ap-
propriate stakeholders meet in person every 2 
years at a scientific exchange meeting. 
3.3 Current NIOSH NTRC 
Intramural Nanotechnology 
Research Activities
Current NIOSH NTRC research activities in 
nanotechnology are focused on occupational 
safety and health implications and applications 
of ENMs. Data gathered from ongoing research 
studies with engineered nanoparticles are used 
to better understand workplace nanoparticle ex-
posures, the hazards posed by nanomaterials, 
and the potential risk of adverse health effects 
from occupational exposures. Studies are also 
providing data on the characteristics of nano-
materials produced and used in the workplace, 
routes of exposure, and the effectiveness of work 
practices and engineering controls in preventing 
worker exposure. Findings from these intramu-
ral studies are providing scientific data to sup-
port the development of occupational safety and 
health recommendations. NIOSH progress and 
accomplishments in nanotechnology research 
can be found in the report Filling the Knowl-
edge Gaps for Safe Nanotechnology in the Work-
place [NIOSH 2012a].
3.3.1 Evaluation of the nanotechnology 
research program
NIOSH evaluates its research progress in nan-
otechnology through a series of internal and 
external reviews. Past reviews of its nanotech-
nology research program have been conduct-
ed by the National Academies and by a work-
group of scientists chaired by two members of 
the NIOSH Board of Scientific Counselors. 
Based on these reviews, a revised strategic plan 
was published in November 2009 that proposed 
focused research and guidance on (1) identi-
fying categories of nanomaterials that can be 
distinguished by their physical and chemical 
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properties; (2) recommending specific expo-
sure limits for various nanomaterials; (3) assess-
ing hazards, risks, and exposures; and (4) devel-
oping intervention strategies [NIOSH 2009b]. 
In addition to external reviews, NIOSH con-
tinues to conduct annual program reviews and 
regular project reviews, and it publishes period-
ic progress reports describing ongoing research 
and accomplishments.
This NIOSH Nanotechnology Research and Guid-
ance Strategic Plan was reviewed by a workgroup 
of scientists chaired by two members of the 
NIOSH Board of Scientific Counselors, and 
public comment was solicited through an an-
nouncement in the Federal Register. 
3.4 Current NIOSH Extramural 
Nanotechnology Research 
Activities
The NIOSH Office of Extramural Pro-
grams (OEP) manages the competitive pro-
cess for awarding occupational safety and 
health grants and cooperative agreements to 
the research community outside the Insti-
tute. This process involves peer review, pro-
gram relevance, and priorities of the Nation-
al Occupational Research Agenda (NORA), 
the NIOSH Research to Practice (r2p) ini-
tiative, congressional mandates, and sector, 
cross-sector, or coordinated emphasis areas of 
the NIOSH Program Portfolio (http://www.
cdc.gov/niosh/programs).
Since 2001, the NIOSH OEP has fund-
ed nanotechnology research through Occupa-
tional Safety and Health Research Program 
Announcements (R01), Mentored Scientist 
Grants (K01), Small Research Grants (R03), 
Developmental Grants (R21), and Small Busi-
ness Innovation Research Grants (R43/44). 
During the period 2001 to 2012, the NIOSH 
OEP has committed approximately $12 mil-
lion to extramural nanotechnology research.* 
Summaries of the projects funded by the 
NIOSH OEP are included in the document 
Filling the Knowledge Gaps for Safe Nanotechnol-
ogy in the Workplace [NIOSH 2012a]. Through 
continued collaboration with the Environmen-
tal Protection Agency/National Center for En-
vironmental Research (EPA/NCER), National 
Science Foundation (NSF), National Institutes 
of Health/National Institute of Environmental 
Health Sciences (NIH/NIEHS), and interna-
tional agencies, the NIOSH OEP continues to 
support nanotechnology research that focuses 
on occupational safety and health issues. In ad-
dition, the NIOSH OEP routinely confers with 
the NIOSH NTRC regarding research needs.
*This includes all extramural projects that involve any as-
pect of nanotechnology.
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4 GOALS
4.1 Address Each Element in the 
Risk Management Continuum 
Ultimately, the goal of the NTRC is to develop 
information, knowledge, and guidance to pro-
tect the nanotechnology workforce. It is rela-
tively early in the emergence of nanotechnolo-
gy and there are many gaps in knowledge, yet 
nano-enabled products are in commerce and 
workers are being exposed to nanomaterials. 
Consequently, there is a need to address all ele-
ments in the risk management continuum con-
currently.
The process for managing potential workplace 
exposures to engineered nanoparticles during 
their synthesis, manufacture, and incorporation 
into new materials and devices consists of the 
following steps to ascertain the appropriate risk 
management strategy: 
1. identifying and characterizing the health 
and safety hazard; 
2. conducting dose-response risk assess-
ment; 
3. assessing the extent of exposure; 
4. characterizing the risk on the basis of 
exposure; and 
5. developing control and management 
procedures [Schulte et al. 2008b]. 
As exposure assessment data for nanomateri-
als become available, the existence of any occu-
pational risk—and the conditions under which 
exposure to the hazard would be harmful to 
workers—can be determined. A goal of the 
risk characterization is to determine wheth-
er exposure to a type of material (in this case, 
nanomaterials) used in a given technology is 
likely to result in adverse health effects. Ex-
posure assessment data provide a means to 
determine whether workers might be exposed 
and what type of control strategy might be ef-
fective in preventing exposure. Epidemiologic 
research is needed to provide etiologic evidence 
for new hazards and quantitative exposure–re-
sponse information for recommended exposure 
limits. Decisions about which nanomaterials to 
study epidemiologically require collecting infor-
mation on workforce size, exposure levels, and 
expected hazard (from toxicological or other in-
formation). The NIOSH NTRC is involved in 
conducting research and answering questions 
posed in each element of the risk management 
process to address knowledge gaps in the pro-
tection of workers (Figure 7). 
A challenge of the NIOSH NTRC program is 
to determine how to conduct timely research 
that addresses the elements of hazard identifi-
cation through risk management, as introduc-
tion of nanomaterials to the workplace contin-
ues and the workforce exposed to them becomes 
more diversified. The approach taken by the 
NTRC has been to conduct concurrent, focused 
research to address knowledge gaps in each step 
of the risk management process to provide oc-
cupational safety and health guidance.
4.2 Identification of NTRC Data 
Needs for Knowledge Gaps
In preparing this strategic plan, the NTRC 
steering committee met in spring 2012 to iden-
tify data needs and research gaps. Information 
was gleaned from various sources: 
 • research studies conducted by the NIOSH 
NTRC and others
 • comments received during public review 
from open meetings or submitted to the 
NIOSH Docket on Interim Guidance for 
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Hazard Identification
“Is there reason to believe 
this could be harmful?”
Risk Management
“Develop procedures to 
minimize exposures”.
Hazard Characterization
“How and under what 
conditions could it be harmful?”
Exposure Assessment
“Will there be exposure in 
real-world conditions?”
Risk Characterization
“Is substance hazardous 
and will there be exposure?”
• Toxicologic research
• Health effects assessment
• Safety research
• Toxicologic research
• Field assessment
• Epidemiologic and hazard
surveillance research
• Metrology research
• Field assessment
• Control technology research
• Personal protective equipment
(PPE) research
• Risk assessment
• Dose-response modeling
• Exposure characterization
• Epidemiologic research
• Risk communication
• Guidance development for
controls, exposure limits, PPE,
and medical surveillance
• Information dissemination
• Adherence investigation
Gaps in the
Protection of Workers NIOSH Focus
Adapted from Gibbs [2006] and NRC [2009].
Figure 7. Addressing knowledge gaps in protecting nanomaterial workers. 
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Medical Screening and Hazard Surveil-
lance for Workers Potentially Exposed to 
Engineered Nanoparticles
 • comments received during public review 
from open meetings or submitted to the 
NIOSH Docket on Current Intelligence 
Bulletin for Occupational Exposure to Car-
bon Nanotubes and Nanofibers
 • comments received in the NIOSH Dock-
et on the draft strategic goals [76 Fed. 
Reg.* 123612]
 • the 2011 NEHI Environmental, Health, 
and Safety (EHS) Research Strategy
 • various scientific meetings and collabo-
rations, including tripartite attendance 
(labor, industry, and government) and 
stakeholder input workshops. 
On the basis of this information, the following 
data needs and research gaps have been identified.
Increase understanding of new hazards and re-
lated health risks to nanomaterial workers
 • Identify emerging commercial ENMs 
through market forecasting and research, 
technology surveillance, and partner and 
stakeholder input. 
 • Determine how workers might be ex-
posed to nanoparticles during manufac-
turing, handling, and use of nanomaterials. 
 — Expand research from primary 
manufacturer to second-, third-, and 
fourth-generation use of ENMs.
 — Continue field investigations to bet-
ter understand worker exposures 
throughout the life cycle, including 
processing of nano-enabled products.
 — Determine how ENMs interact with 
the body’s systems.
 — Determine relationships between 
specific physicochemical properties 
of ENMs and adverse biological effects. 
*Federal Register. 
Expand understanding of the initial hazard 
findings of engineered nanomaterials 
 • Determine carcinogenicity of carbon nano-
tubes (CNTs).
 • Determine whether the cardiovascular sys-
tem is more sensitive than the lungs to ef-
fects from ENM exposures.
 • Determine whether ENMs cause im-
mune dysfunction.
 • Explore the usefulness of biomarkers for 
identifying and determining the extent 
of worker exposure and the potential for 
adverse health effects.
 • Conduct research on measurement meth-
ods for nanomaterials.
 — Align laboratory and field exposure 
metrics and measurement techniques.
 — Expand and refine workplace mea-
surement techniques for assessing 
exposure (tiered approach).
 — Develop a microscopy method for 
CNTs and other ENMs. 
 — Identify the critical reference materi-
als needed for measurement.
 • Continue to evaluate additional ENMs 
for dustiness, explosibility, flammability, 
and electromagnetic hazard potential.
 — Correlate dustiness, explosion, fire, 
and electromagnetic data with exist-
ing hazard indexes.
Support the creation of guidance materials 
to inform nanomaterial workers, employers, 
health professionals, regulatory agencies, and 
decision-makers about the hazards, risk, and 
risk management approaches. 
 • Develop categorical and specific occupa-
tional exposure limits.
 — Conduct research to recommend 
specific exposure limits for various 
ENMs (e.g., nanosilver, graphene, 
carbon black, nano silica, nanoceram-
ics, nano clays, nano catalysts), and 
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evaluate the adequacy of existing ex-
posure limits.
 • Identify categories of nanomaterials that 
can be distinguished by physicochemical 
parameters. 
 • Conduct risk assessments.
 — Nanoparticle lung dosimetry mod-
eling
 — Categorization and comparative po-
tency methods
 • Link risk assessment, toxicology, expo-
sure measurement, and control strategies.
 • Demonstrate effective risk management 
practices.
 • Develop guidance materials.
 — Update guidance for medical surveil-
lance (include sensitivity and speci-
ficity of medical tests). 
 — Evaluate and provide guidance on 
control technology.
 — Integrate Prevention through Design 
(PtD) into ENM risk management 
guidelines. 
 — Use categorical approaches for ENMs 
to develop guidance on controlling 
exposures (hazard and control band-
ing).
 — Evaluate and provide guidance on 
PPE for use with ENMs.
 • Partner with businesses to promote safe 
and responsible handling of ENMs.
 • Determine whether there are potential ap-
plications of nanomaterials for safety and 
health (e.g., improved sensors or PPE).
Support epidemiologic studies for nanomate-
rial workers, including medical, cross-section-
al, prospective cohort and exposure studies. 
 • Conduct epidemiologic research on the 
health of nanomaterial workers by em-
ploying both cross-sectional and pro-
spective designs.
 • Partner with other U.S. agencies and 
groups that have begun epidemiologic 
and other surveillance studies.
 • Determine appropriate tools for medi-
cal screening and mechanisms of medical 
surveillance among workers exposed to 
specific EMNs.
 • Create an exposure database that harmo-
nizes with global exposure databases.
Assess and promote national and internation-
al adherence with risk management guidance
 • Conduct a national assessment to de-
termine the extent of use of nanomate-
rial exposure controls and any barriers to 
their use.
 • Provide intervention strategies for indus-
try sectors where adherence to good risk-
management practices is low.
 • Partner with other businesses, U.S. agen-
cies, and the international community to 
promote safe, responsible development of 
nanomaterials.
4.3 Coalescing Priorities for 
NIOSH NTRC Research and 
Guidance for FY2013–FY2016 
The NIOSH NTRC has proposed specific re-
search activities (see Section 4.5) for FY2013–
FY2016 that address the previously identified 
research needs and gaps (Section 4.2). Figure 
8 provides a schema for how NIOSH will fo-
cus its research activities in accordance with the 
goals of the NTRC Strategic Plan:
 • Increase understanding of new hazards 
and related health risks to nanomaterial 
workers.
 • Expand understanding of the initial haz-
ard findings of engineered nanomaterials.
 • Support the creation of standards and guid-
ance materials to inform nanomaterial 
workers, employers, health professionals, 
regulatory agencies, and decision-makers 
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about hazards, risks, and risk manage-
ment approaches.
 • Support epidemiologic studies for nano-
material workers, including medical, 
cross-sectional, prospective cohort, and 
exposure studies. 
 • Assess and promote national and inter-
national adherence with risk manage-
ment guidance.
The overall focus of the strategic plan will be 
to continue to generate data, information, and 
knowledge to protect the nanotechnology 
workforce, by using effective risk management 
techniques and particularly keeping exposure 
below occupational limits. Research is proposed 
to develop and update good risk-management 
practices, including categorical and specif-
ic exposure limits. Research data and informa-
tion will be cataloged and shared via informat-
ics (resources, devices, and methods required to 
optimize the acquisition, storage, retrieval, and 
use of information).
4.4 Coordination with the 
National Nanotechnology 
Initiative
NIOSH research priorities address many of the 
strategic goals proposed by the NNI Strategy 
for Nanotechnology Environmental, Health, 
and Safety Research. Table 1 shows the align-
ment of the NIOSH NTRC strategic goals and 
10 NTRC critical research areas with the NNI 
EHS priority research needs (Appendix A). 
4.5  Proposed NIOSH 
NTRC Research
The following proposed research for FY2013–
FY2016 has been coalesced to focus on specif-
ic research needs to fill data gaps (see Section 
4.2) and the EHS priority research needs of the 
NNI (see Section 4.4). As knowledge gaps are 
filled and as resources become available, these 
research priorities could change. 
Strategic Goal 1 (PPNANSG1): Increase un-
derstanding of new hazards and related health 
risks to nanomaterial workers.  
Intermediate Goal 1.1 (PPNANIG1.1): Conduct 
market forecasting and review available sur-
veillance data to determine emerging commer-
cial ENMs and next-generation uses of exist-
ing ENMs.
Activity/Output Goal 1.1.1 (PPNANAOG1.1.1): 
Prioritize high-volume emerging ENMs to 
identify the next candidates for toxicological 
testing and field evaluation of workplace expo-
sures.
Performance Measure 1.1.1: In FY2013, com-
plete an initial market research and forecasting 
report for internal use. Update the report with-
in 3 years. 
Activity/Output Goal 1.1.2 (PPNANAOG1.1.2): 
Complete a secondary market analysis on high 
volume nanomaterials. 
Performance Measure 1.1.2: By FY2014, 
complete a market landscape analysis of formu-
lators and users of nano titanium dioxide, silver, 
graphene and cellulose. Identify key industries 
using these materials in current products and 
those to be commercialized in the near term. 
Intermediate Goal 1.2 (PPNANIG1.2): Conduct 
research to contribute to the understanding of the 
toxicology and internal dose of emerging ENMs.
Activity/Output Goal 1.2.1 (PPNANAOG1.2.1): 
Evaluate acute and chronic effects in the lungs 
and in other organ systems and tissues. Deter-
mine dose-response and time-course relation-
ships. Determine rates of clearance of these 
nanoparticles after pulmonary exposure and 
translocation to systemic organs; characterize 
systemic effects.
Performance Measure 1.2.1: Complete tox-
icologic studies on ENMs such as nanosilver, 
graphene, and nanocellulose; present the data 
via the Society of Toxicology and publish in the 
peer-reviewed literature by FY2016. 
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Performance Measure 1.2.2: Identify probable 
combinations of nanomaterial uses and if fre-
quent combinations are identified, conduct pre-
liminary toxicologic evaluations to determine if 
synergistic effects occur by FY2016.
Intermediate Goal 1.3 (PPNANIG1.3): Deter-
mine whether nanomaterial toxicity can be cat-
egorized on the basis of physicochemical prop-
erties and mode of action.
Activity/Output Goal 1.3.1 (PPNANAOG1.3.1): 
Systematically investigate the physical and chem-
ical properties of particles that influence their 
toxicity (e.g., size, shape, surface area, solubility, 
chemical properties, and trace components). 
Activity/Output Goal 1.3.2 (PPNANAOG1.3.2.): 
Determine the biological mechanisms for tox-
ic effects (e.g., oxidant stress, dissolution, fibro-
genicity, and hydrophobicity) and how the key 
chemical and physical factors may influence 
these mechanisms. 
Activity/Output Goal 1.3.3 (PPNANAOG1.3.3): 
Integrate mechanistic models (including an-
imal models and in vitro screening tests) for 
assessing the potential toxicity of new nano-
materials, and provide a basis for developing 
predictive algorithms for structure/function re-
lationships and comparative toxicity analyses 
for risk assessment. Determine whether toxico-
logic data from new studies can be linked to ex-
isting toxicologic data.
Performance Measure 1.3.1: By FY2016, de-
termine whether ENMs can be categorized 
(hazard banded) on the basis of physicochemical 
properties and/or the toxicologic mode of action. 
Intermediate Goal 1.4 (PPNANIG1.4): Con-
duct nanomaterial workplace exposure assess-
ments at sites developing, producing, or using 
emerging ENMs. 
Activity/Output Goal 1.4.1 (PPNANAOG1.4.1): 
Collaborate with nanomaterial businesses to 
identify processes that may release nanomate-
rials during manufacturing or use of ENMs. 
Evaluate potential exposures and document 
risk mitigation processes. 
Performance Measure 1.4.1.1: Complete a 
minimum of four field evaluations per year at 
facilities producing or using emerging ENMs. 
By FY2014, publish summary findings in a 
peer-reviewed journal.
Performance Measure 1.4.1.2: Evaluate ENM 
use and risk management practices at user fa-
cilities across the life cycle, including secondary 
and tertiary facilities. By FY2015, publish sum-
mary findings in a peer-reviewed journal.
Strategic Goal 2 (PPNANSG2): Expand un-
derstanding of the initial hazard findings of 
engineered nanomaterials.
Intermediate Goal 2.1 (PPNANIG2.1): Conduct 
research to evaluate the adverse chronic effects 
of single-walled carbon nanotubes, multi-walled 
carbon nanotubes, and carbon nanofibers. 
Activity/Output Goal 2.1.1 (PPNANAOG2.1.1): 
Conduct toxicologic testing to determine the 
potential of single-walled carbon nanotubes, 
multi-walled carbon nanotubes, and carbon 
nanofibers to have long-term pulmonary effects 
(fibrosis, lung cancer, mesothelioma). 
Performance Measure 2.1.1: By FY2016, pub-
lish a report on the carcinogenicity of carbona-
ceous nanomaterials, based on completed carci-
nogenicity-toxicology studies.
Intermediate Goal 2.2 (PPNANIG2.2): Deter-
mine whether human biomarkers of nanomate-
rial exposure and/or response can be identified.
Activity/Output Goal 2.2.1 (PPNANAOG2.2.1): 
Conduct research to determine whether blood, 
urine, or nasal lavage markers can accurately 
predict initiation and progression of adverse re-
sponses to ENMs. 
Performance Measure 2.2.1: By FY2017, pub-
lish results of human biomarker studies.
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Activity/Output Goal 2.2.2 (PPNANAOG2.2.2): 
Conduct research to determine whether car-
diovascular or immune responses are sensitive 
indicators of pulmonary exposure to ENMs. 
Performance Measure 2.2.2: By FY2016, pub-
lish findings on cardiovascular and immune re-
sponses to pulmonary exposure to ENMs.
Intermediate Goal 2.3 (PPNANIG2.3): De-
termine the relevance of in vitro and in vivo 
screening tests to worker response to inhala-
tion of ENMs.
Activity/Output Goal 2.3.1 (PPNANAOG 2.3.1): 
Evaluate the relationship of deposition patterns 
and biological responses to pulmonary bolus 
exposure (intratracheal instillation or pharyn-
geal aspiration) vs. exposure extended over time 
(inhalation) of ENMs in rodent models.
Performance Measure 2.3.1: By FY2016, pub-
lish findings on the relationship of deposition 
patterns and biological responses to pulmonary 
bolus exposure vs. exposure extended over time.
Activity/Output Goal 2.3.2 (PPNANAOG 2.3.2): 
Evaluate predictive in vitro screening tests for 
fibrogenicity, genotoxicity, and/or cell transfor-
mation.
Performance Measure 2.3.2: Publish results 
from predictive in vitro screening tests for fibro-
genicity, genotoxicity, and/or cell transformation, 
over the next 2 to 4 years (FY2014–FY2016). 
Intermediate Goal 2.4 (PPNANIG2.4): Con-
duct research on measurement methods for 
nanomaterials.
Activity/Output Goal 2.4.1 (PPNANAOG2.4.1): 
Continue interactions with national metrology 
institutes and qualify cellulose and single-walled 
CNT nanoscale reference materials (RMs) and/
or benchmark materials for evaluating measure-
ment tools, instruments, and methods for expo-
sure assessment and toxicology. 
Performance Measure 2.4.1.1: By FY2014, com-
plete a round-robin evaluation of a transmission 
electron microscopy (TEM) sample-preparation 
procedure using National Institute of Stan-
dards and Technology (NIST) gold nanoparti-
cle RMs 8011, 8012, and 8013. 
Performance Measure 2.4.1.2: By FY2014, 
translate this TEM sample-preparation proce-
dure into a consensus standard practice or guide 
through ASTM International Committee E56: 
Nanotechnology. 
Performance Measure 2.4.1.3: Within 4 years 
(FY2016), utilize NIST gold nanoparticle RMs 
8011, 8012, and 8013 to evaluate filter- and 
grid-based sample-collection techniques and 
TEM analysis for spherical ENMs. 
Performance Measure 2.4.1.4: By FY2016, 
develop measurement protocols for dynamic 
light scattering (hydrodynamic diameter), laser 
Doppler electrophoresis (zeta potential), and 
gas adsorption (surface area) measurements 
that utilize RMs (as appropriate) for particle 
characterization for internal use to promote re-
producibility of testing. 
Performance Measure 2.4.1.5: By FY2016, 
develop instrument sampling cards that pro-
vide a succinct summary on the operation and 
utility of condensation particle counters, scan-
ning mobility particle sizers, and diffusion 
chargers for internal use to promote measure-
ment quality. 
Activity/Output Goal 2.4.2 (PPNANAOG2.4.2): 
Understand relationships between laboratory 
instrumentation used to characterize aerosols 
for toxicology studies and field-measurement 
instrumentation used to characterize workplace 
atmospheres.
Performance Measure 2.4.2: By FY2016, com-
plete a series of studies to evaluate test atmo-
spheres with real-time and integrated labora-
tory and field-measurement instruments for 
a range of metrics, including particle number, 
size, and surface area. 
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Activity/Output Goal 2.4.3 (PPNANAOG2.4.3): 
Conduct further research on the dustiness testing 
of powders and to benchmark the Venturi (Uni-
versity of North Carolina) dustiness testing de-
vice against a more traditional dustiness test (e.g., 
a standard method prescribed in EN 15051).
Performance Measure 2.4.3: By FY2015, com-
pare the Venturi dustiness testing device against 
at least one other method for a range of fine 
and nanoscale materials.
Activity/Output Goal 2.4.4 (PPNANAOG2.4.4): 
Conduct further research on determining the 
advantages and limitations of direct reading in-
struments in assessing nanoparticle work-place 
emissions and exposures.
Performance Measure 2.4.4: By FY2015, pub-
lish at least one further study on the perfor-
mance of direct reading instruments for assess-
ing nanoparticle emissions or exposures in the 
workplace.
Activity/Output Goal 2.4.5 (PPNANAOG2.4.5): 
Develop and improve methods and approach-
es (including direct reading and time-integrat-
ed sampling) for assessing workplace exposures 
to ENMs. 
Performance Measure 2.4.5.1: By FY2015, 
publish updated strategies for assessing work-
place exposures.
Performance Measure 2.4.5.2: By FY2015, 
validate method 5040 for a series of CNT in-
cluding. NIST Standard Reference Materi-
al 248: Single-Wall Carbon Nanotubes (Raw 
Soot).
Activity/Output Goal 2.4.6 (PPNANAOG2.4.6): 
Evaluate scanning electron microscopy, trans-
mission electron microscopy, and dark-field mi-
croscopy as analytical tools for measurement of 
carbon nanotubes using NIST Standard Refer-
ence Material 248: Single-Wall Carbon Nano-
tubes (Raw Soot). 
Performance Measure 2.4.6: By FY2015, pub-
lish a microscopy method (or methods) for 
sample preparation, identification, and/or pos-
sible semi-quantification that is applicable to 
some ENMs. 
Activity/Output Goal 2.4.7 (PPNANAOG2.4.7): 
Conduct research to advance the use of nano-
materials in the development of sensors (e.g., 
detection of harmful chemicals) and oth-
er health and safety–related applications that 
can be used in the workplace to ensure effective 
control of exposure.
Performance Measure 2.4.7.1: By FY2016, 
develop an effective sensor employing nano-
materials for the real-time measurement of a 
workplace agent, and publish the results.
Performance Measure 2.4.7.2: By FY2016, 
compile and publish a compendium on appli-
cations of nanotechnology to improve work-
place safety and health.
Intermediate Goal 2.5 (PPNANIG2.5): Con-
duct research to better define the potential fire 
and explosion safety hazards of ENMs.
Activity/Output Goal 2.5.1 (PPNANAOG2.5.1): 
Identify physical and chemical properties that 
contribute to dustiness, combustibility, flam-
mability, explosibility, and electromagnetic haz-
ards of ENMs. 
Performance Measure 2.5.1: By FY2014, pub-
lish preliminary findings from explosibility test-
ing of some ENMs. 
Performance Measure 2.5.2: By FY2016, pub-
lish findings that may influence the National 
Fire Protection Association (NFPA) or Depart-
ment of Transportation (DOT) flammability 
placard information and the DOT Emergency 
Response Guidebook.
Intermediate Goal 2.6 (PPNANIG2.6): Devel-
op and use informatics to process and commu-
nicate information.
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Activity/Output Goal 2.6.1 (PPNANAOG2.6.1): 
Create a harmonized database to share exposure 
measurement, control, and epidemiologic data. 
Performance Measure 2.6.1: By FY2015, have a 
populated dataset containing NIOSH results on 
measurement, control, and epidemiologic data.
Activity/Output Goal 2.6.2 (PPNANAOG2.6.2): 
Lead the nanoinformatics community to devel-
op an open literature monograph on nanoinfor-
matics principles and practice.
Performance Measure 2.6.2: Complete and 
publish the nanoinformatics monograph by 
FY2015.
Strategic Goal 3 (PPNANSG3): Support the 
creation of guidance materials to inform 
nanomaterial workers, employers, health pro-
fessionals, regulatory agencies, and decision-
makers about hazards, risks, and risk man-
agement approaches.
Intermediate Goal 3.1 (PPNANIG3.1): Develop 
categorical and specific exposure limits.
Activity/Output Goal 3.1.1(PPNANAOG3.1.1): 
Conduct a risk assessment for high-volume 
ENMs.
Performance Measure 3.1.1: By FY2015, com-
plete a quantitative risk assessment (QRA) on 
ultrafine and fine materials from existing stud-
ies. Evaluate QRA methods for nanomaterials. 
Start QRA for nanoparticles, with use of new 
NIOSH data. Use NIOSH nanoparticle data 
to calibrate and validate dosimetry models for 
nanoparticles. 
Activity/Output Goal 3.1.2 (PPNANAOG3.1.2): 
Develop a risk-assessment framework for eval-
uating the hazard and predicting the risk of ex-
posure to ENMs. 
Performance Measure 3.1.2: By 2017, devel-
op a risk-assessment framework to rank haz-
ard and estimate risk from exposure to selected 
ENMs in the workplace.
Activity/Output Goal 3.1.3 (PPNANAOG3.1.3): 
Use a nanomaterial hazard banding classifica-
tion scheme to group ENMs. 
Performance Measure 3.1.3: By FY2016, de-
velop a hazard banding classification scheme 
for ENMs on the basis of toxicological, chemi-
cal, and physical properties.  
Intermediate Goal 3.2 (PPNANIG3.2): Con-
duct research to better understand engineering 
controls and PPE for use with ENMs.
Activity/Output Goal 3.2.1 (PPNANAOG3.2.1): 
Evaluate the effectiveness of engineering con-
trol techniques for ENMs and develop new ap-
proaches as needed. 
Performance Measure 3.2.1: Conduct field 
investigations of workplaces where ENMs are 
manufactured and used to evaluate existing en-
gineering controls and make recommendations 
on improving exposure control. By FY2015, 
publish case studies and workplace survey re-
ports, and by FY 2016, publish updated engi-
neering control solutions. 
Activity/Output Goal 3.2.2 (PPNANAOG3.2.2): 
Conduct laboratory evaluations of commercial-
ly available engineering controls for a variety 
of common ENM production, handling, and 
downstream processes.
Performance Measure 3.2.2: By FY2016, pub-
lish in-depth reports and journal articles on the 
effectiveness of the commercially available en-
gineering control devices. 
Activity/Output Goal 3.2.3 (PPNANAOG3.2.3): 
Evaluate the effectiveness of PPE (respirators, 
and protective clothing including gloves) for 
reducing worker exposures to ENMs.
Performance Measure 3.2.3: By FY2016, pub-
lish updated guidance on the effectiveness of 
PPE for reducing worker exposures to ENMs. 
Intermediate Goal 3.3 (PPNANIG3.3): Incor-
porate Prevention through Design (PtD) into 
nanomaterial health and safety programs.
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Activity/Output Goal 3.3.1 (PPNANAOG3.3.1): 
Promote PtD principles for nanomaterials, in-
cluding safer nanomaterials that have the same 
functionality; process containment and con-
trol; and management system approaches to in-
clude occupational safety and health into the 
nanoparticle synthetic process, product devel-
opment, and product manufacture.
Performance Measure 3.3.1: By FY2015, 
publish a document specific to PtD for nano-
materials.
Intermediate Goal 3.4 (PPNANIG3.4): Foster 
the collection, management, and dissemination 
of relevant information to protect nanomateri-
al workers.
Activity/Output Goal 3.4.1 (PPNANAOG3.4.1): 
Develop and disseminate effective information, 
education, and training materials to various tar-
get audiences such as nanotechnology workers 
and employers, occupational safety and health 
professionals, policy-makers, decision-makers, 
and/or the scientific community.
Performance Measure 3.4.1.1: By FY2015, 
create nanomaterial guidance documents for 
workers, including small business and construc-
tion workers.
Performance Measures 3.4.1.2: By FY2015, 
update Approaches to Safe Nanotechnology: Man-
aging the Safety and Health Concerns Associated 
with Engineered Nanomaterials.
Performance Measures 3.4.1.3: By FY2016, up-
date the Progress Report on the NIOSH Nano-
technology Research and Communication Effort. 
Performance Measure 3.4.1.4: Create new 
guidance documents on use of engineering con-
trols, PPE, and PtD, as per Performance Mea-
sures 3.2.1, 3.2.2, 3.2.3, and 3.3.1. 
Performance Measure 3.4.1.5: By FY2016, 
support a conference on risk management of 
ENMs, with a focus on engineering controls.
Performance Measure 3.4.1.6: By FY2016, 
evaluate Nanomaterial Safety Data Sheets for 
adherence with the updated OSHA HazCom 
rule (including the use of Global Harmoniza-
tion System), and issue guidance documents 
based on the updated findings.
Intermediate Goal 3.5 (PPNANIG3.5): Enhance 
global workplace safety and health through in-
ternational activities.
Activity/Output Goal 3.5.1 (PPNANAOG3.5.1): 
Establish and maintain national and interna-
tional partnerships so that knowledge gaps, re-
search needs and priorities, approaches, and da-
tabases could be shared.
Performance Measure 3.5.1.1: Strengthen co-
ordination of research through government-
level organizations such as the Organization 
for Economic Cooperation and Development 
(OECD) and United Nations (UN). 
Performance Measure 3.5.1.2: By FY2015, 
expand collaborations to developing nations.
Activity/Output Goal 3.5.2 (PPNANAOG3.5.2): 
Improve sharing critical data globally.
Performance Measure 3.5.2.1: By FY016, de-
velop a global portal for information on ENMs 
relevant to occupational safety and health.
Performance Measure 3.5.2.2: If feasible, by 
FY2016 initiate the development of a global 
exposure registry database. 
Performance Measure 3.5.2.3: In FY2015, par-
ticipate in OECD Nanomaterial Safety Testing 
Program by sponsoring nanomaterial testing and 
by data exchange. 
Activity/Output Goal 3.5.3 (PPNANAOG 3.5.3): 
Lead the development of global standards on oc-
cupational safety and health for nanotechnology.
Performance Measure 3.5.3.1: Over the next 
3 years (FY2014–FY2016), lead the develop-
ment of at least one standard in the Interna-
tional Organization for Standardization.
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Performance Measure 3.5.3.2: Over the next 3 
years (FY2014–FY2016), lead the development 
of at least one guidance document for the UN.
Performance Measure 3.5.3.3: Over the next 3 
years (FY2014–FY2016), lead the development 
of at least one guidance document for the OECD. 
Strategic Goal 4 (PPNANSG4): Support epi-
demiologic studies for nanomaterial workers, 
including medical, cross-sectional, prospec-
tive cohort, and exposure studies.
Intermediate Goal 4.1 (PPNANIG4.1): Con-
duct epidemiologic research and evaluate fea-
sibility of conducting surveillance of nanoma-
terial workers.
Activity/Output Goal 4.1.1 (PPNANAOG4.1.1): 
Complete the epidemiological health studies 
of U.S. workers exposed to CNTs and carbon 
nanofibers.
Performance Measure 4.1.1: By FY2016, 
complete data collection for industry-wide ex-
posure and epidemiological studies of workers 
exposed to carbonaceous nanomaterials.
Activity/Output Goal 4.1.2 (PPNANAOG4.1.2): 
Evaluate the need for and feasibility of initiat-
ing worker exposure registries for workers ex-
posed to existing nanomaterials (e.g., titanium 
dioxide, CNTs) or producing and using new 
nanomaterials. 
Performance Measure 4.1.2: By FY2016, de-
velop a template and begin population of work-
er exposure registries.
Activity/Output Goal 4.1.3 (PPNANAOG4.1.3): 
Integrate nanotechnology safety and health 
guidance into existing hazard surveillance sys-
tems. Determine whether these systems are ad-
equate by conducting evaluations.
Performance Measure 4.1.3: By FY2016, 
update NIOSH Current Intelligence Bulletin 
60: Interim Guidance for the Medical Screen-
ing and Hazard Surveillance of Workers Po-
tentially Exposed to Engineered Nanoparticles 
[NIOSH 2009d]. 
Strategic Goal 5 (PPNANSG5): Assess and 
promote national and international adher-
ence with risk management guidance.
Intermediate Goal 5.1 (PPNANIG5.1): Deter-
mine the extent to which control measures are 
being adopted by industry. Identify any barriers 
to use of controls and partner with business to 
address barriers.
Activity/Output Goal 5.1.1 (PPNANAOG 
5.1.1): Determine whether NIOSH or other 
precautionary guidance recommendations are 
being adopted by businesses. 
Performance Measure 5.1.1: Within the next 
3 years, conduct formal and informal assess-
ments of the controls used in ENM-produc-
ing or -handling facilities. By FY2016, publish 
findings.
Activity/Output Goal 5.1.2 (PPNANAOG 5.1.2): 
Develop a plan for industrial sectors where ad-
herence to good risk-management practice is 
low.
Performance Measure 5.1.2: By 2016, publish 
a plan for intervening in industry sectors with 
low adherence to risk management guidance.
Activity/Output Goal 5.1.3 (PPNANAOG 5.1.3): 
Develop a follow-back program for the field in-
vestigation activities.
Performance Measure 5.1.3: By 2014, have a 
follow-back program in place to determine if 
facilities are implementing suggestions from 
the field investigations.
Activity/Output Goal 5.1.4 (PPNANAOG 5.1.4): 
Support the International Commission on Oc-
cupational Health (ICOH) and other orga-
nizations in assessing whether precautionary 
guidance recommendations are being adopted 
worldwide. 
Performance Measure 5.1.4: By 2016, sup-
port ICOH in developing a plan to address lo-
cations where adherence to good risk-manage-
ment practice is low. 
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5 OUTPUTS 
A summary of NIOSH NTRC research out-
puts and accomplishments is presented in the 
report Filling the Knowledge Gaps for Safe Nano-
technology in the Workplace [NIOSH 2012a].
5.1 NIOSH Publications on 
Nanotechnology Since 2009
NIOSH NTRC scientists will continue to de-
velop documentation that provides guidance 
and technical information for workers, employ-
ers, health professionals, regulatory agencies, 
and decision-makers in government, academia, 
industry, and labor. Examples of such documen-
tation include the following:
 • Current Intelligence Bulletin (CIB) 65, Oc-
cupational Exposure to Carbon Nanotubes 
and Carbon Nanofibers, DHHS (NIOSH) 
Publication No. 2013–145 [NIOSH 2013]. 
This document includes a recommended 
exposure limit for carbon nanotubes and 
nanofibers. It is available at http://www.cdc.
gov/niosh/docs/2013-145/.
 • Filling the Knowledge Gaps for Safe Nan-
otechnology in the Workplace, DHHS 
(NIOSH) Publication No. 2013–101 
[NIOSH 2012a]. It is available at http://
www.cdc.gov/niosh/docs/2013-101/. 
 • Current Intelligence Bulletin (CIB) 63, Oc-
cupational Exposure to Titanium Dioxide, 
DHHS (NIOSH) Publication No. 2011–
160 [NIOSH 2011]. This document in-
cludes a recommended exposure limit for 
both fine and ultrafine (nano) titanium 
dioxide (TiO2). It is available at http://
www.cdc.gov/niosh/docs/2011-160/.
 • General Safe Practices for Working with 
Engineered Nanomaterials in Research 
Laboratories, DHHS (NIOSH) Publi-
cation No. 2012–147 [NIOSH 2012b]. 
It is available at http://www.cdc.gov/niosh/
docs/2012-147/ .
 • NIOSH sponsored a supplement to the 
Journal of Occupational and Environmental 
Medicine, entitled Selected Papers from the 
Nanomaterials and Worker Health, Medi-
cal Surveillance, Exposure Registries and 
Epidemiologic Research Conference, July 
21–23, 2010 [ JOEM 53(6S):S1–S112]. 
 • Progress Toward Safe Nanotechnology in 
the Workplace: A Report from the NIOSH 
Nanotechnology Research Center, DHHS 
(NIOSH) Publication No. 2010–104 
[NIOSH 2009a]. This document reports 
on the status of nanotechnology research 
conducted by the NIOSH NTRC in 
2007–2008. It is available at http://www.
cdc.gov/niosh/docs/2010-104/.
 • Approaches to Safe Nanotechnology: Manag-
ing the Health and Safety Concerns Associat-
ed with Engineered Nanomaterials, DHHS 
(NIOSH) Publication No. 2009–125 
[NIOSH 2009c]. This document served 
a dual purpose of summarizing NIOSH’s 
current thinking and interim recommen-
dations and fostering the exchange infor-
mation to ensure that no worker suffers 
material impairment of safety or health as 
nanotechnology develops. It is available at 
http://www.cdc.gov/niosh/docs/2009-125/.
 • Interim Guidance for Medical Screening 
and Hazard Surveillance for Workers Poten-
tially Exposed to Engineered Nanoparticles, 
DHHS (NIOSH) Publication No. 2009–
116 [NIOSH 2009d]. This document 
recommended prudent precautionary in-
terim measures for reducing work-related 
exposures and assessing potential risk. It 
is available at http://www.cdc.gov/niosh/
docs/2009-116/. 
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5.2 NIOSH Peer-Reviewed 
Publications
NIOSH NTRC scientists will continue to 
publish results of research as the data become 
available. More than 500 peer-reviewed articles 
were published between 2004 and 2012 that 
addressed scientific and technical issues in the 
field of nanotechnology. NIOSH will contin-
ue to evaluate the utility of its publications and 
their impact on the scientific, regulatory, and 
occupational health community. 
5.3 Sponsored Conferences
The NIOSH NTRC will continue to partner 
with others in sponsoring and conducting con-
ferences on nanotechnology. To date, NIOSH 
has co-sponsored 15 international nanomate-
rial health and safety meetings. NTRC staff 
members also have participated on several sci-
entific and technical panels convened by gov-
ernment agencies, nongovernmental agencies, 
and professional associations. 
5.4 Presentations 
NTRC staff will continue to deliver presenta-
tions nationally and internationally concerning 
occupational safety and health issues associat-
ed with nanotechnology, including presenta-
tions at scientific conferences and to trade and 
professional associations. To date, NTRC staff 
members have given more than 650 presenta-
tions on nanomaterial health and safety topics.
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6 RESEARCH TO PRACTICE (r2p)
Research to practice (r2p) involves the transla-
tion of research into products, practices, and us-
able information. The NIOSH NTRC nano-
technology strategic plan reflects the r2p vision 
to work with partners and stakeholders to trans-
late research findings into NIOSH products (e.g., 
guidance documents, instrumentation, nanopar-
ticle filtration methods, and exposure controls) 
that will be used to reduce or prevent worker in-
jury and illness from nanotechnology. R2p also 
involves moving others to action. NIOSH will 
continue to work with national and international 
organizations to translate research to actions that 
will protect the nanomaterial workforce. 
6.1 Capacity Building through 
Technical Assistance
The NIOSH NTRC is currently collaborat-
ing with a number of industries to develop 
appropriate engineering controls and ef-
fective administrative practices for the safe 
handling of nanomaterials. Specifically, the 
NTRC will continue to work with indus-
try and labor in evaluating workplace expo-
sures to ENMs and provide recommenda-
tions that will minimize worker exposures. 
NIOSH has several complimentary re-
sources that reside in the Health Hazard 
Evaluation, Industrywide Study, and Engi-
neering Control Technology Programs that 
can provide expertise in augmenting ongo-
ing NTRC efforts of evaluating workplace 
nanoparticle exposures, related health ef-
fects, and risk management efforts.The 
NIOSH NTRC will continue to make rec-
ommendations and provide information 
based on its research and findings report-
ed in the published scientific literature. The 
recommendations will pertain to all areas of 
risk management described in Section 4.1. 
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7  INTERMEDIATE CUSTOMERS 
    AND INTERMEDIATE OUTCOMES
7.1 Federal Government Agencies
NIOSH will conduct and coordinate research 
with other agencies to foster the responsible 
development and safe use of nanotechnology, 
as identified by the NNI. Specifically, NIOSH 
will continue to collaborate with OSHA, EPA, 
NIST, NIEHS, and the Consumer Product 
Safety Commission (CPSC).
7.2 Standards Development 
Organizations 
NIOSH actively participates in the develop-
ment of national and international standards 
for promoting the health and safety of workers 
in the nanotechnology industries. The NIOSH 
NTRC participates in the American Nation-
al Standards Institute (ANSI) Nanotechnolo-
gy Standards Steering Panel, which coordinates 
the identification and development of critical 
standards in all areas of nanotechnology. 
NIOSH NTRC scientists also participate in the 
ASTM International E56 Committee on Nan-
otechnology, which is developing an integrated 
family of standards. Committee E56.03 is ad-
dressing environmental and occupational safe-
ty and health. 
NIOSH NTRC scientists will continue leading 
as chair and members of the U.S. Technical Ad-
visory Group to the International Organization 
for Standardization (ISO) Technical Commit-
tee 229 on Nanotechnologies (ISO TC 229). 
Work on instrumentation-related standards will 
continue with committees of the International 
Electrotechnical Commission (IEC).
NIOSH NTRC scientists will also contin-
ue collaboration on the development of nano-
technology-related guidance with authoritative 
bodies including the National Council on Radi-
ation Protection and Measurements.
7.3 Industry, Labor, and Academia 
NIOSH is coordinating input from industry, 
labor, academics, and a wide range of govern-
ment agencies in creating guidance for occu-
pational health surveillance. Additionally, the 
NIOSH NTRC plans to coordinate input 
from those same groups of partners and stake-
holders with the goal of developing standard-
ized data systems for epidemiological research 
in workplaces producing and using nanoma-
terials. Through collaborations with industry, 
government, and academia, NIOSH [2009c] 
has developed a “best practices” document, 
Approaches to Safe Nanotechnology: Managing 
the Health and Safety Concerns Associated with 
Engineered Nanomaterials [DHHS (NIOSH) 
Publication No. 2009–125; http://www.cdc.
gov/niosh/docs/2009-125/] and will continue 
to develop other communication materials on 
the safe handling of ENMs. NIOSH NTRC is 
continuing to work with industry to character-
ize occupational exposure to ENMs and im-
plement effective risk-management practices 
to minimize worker exposure to ENMs. 
7.4 Professional Organizations
NIOSH is collaborating with various profes-
sional organizations, including the American 
Industrial Hygiene Association (AIHA) and 
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National Safety Council (NSC), to identify 
mutual efforts for developing new worker train-
ing programs. 
7.5 Research Collaborations
NIOSH has established several national and 
international collaborations to advance re-
search into the safe use of nanotechnology. The 
NIOSH NTRC participates in the National 
Nanotechnology Initiative (NNI) and has con-
tributed to the nanotechnology environmental, 
health, and safety (EH&S) research strategy for 
the nation through the working group of Nan-
otechnology Environmental and Health Impli-
cations (NEHI). NIOSH’s strategic research 
plan and activities have been developed to ad-
dress the occupational safety and health issues 
in the NSET/NEHI plan [NNI 2011]. 
7.6 International Activities 
NIOSH will continue to engage with a num-
ber of international entities at all levels—as prin-
ciple investigator as well as in national, region-
al, and global organizations. At the national 
organization level, the NIOSH NTRC has 
been communicating and collaborating with 
the United Kingdom Institute of Occupational 
Medicine and the Health and Safety Laborato-
ry; the Netherlands Organization for Applied 
Scientific Research (TNO); the French Agen-
cy for Food, Environmental and Occupational 
Health and Safety (ANSES); the Finnish In-
stitute of Occupational Health; and the Aus-
tralian Safety and Compensation Council (Safe 
Work Australia).
NIOSH is collaborating with the OECD to 
build cooperation, coordination, and commu-
nication between the United States and 30 
OECD member countries, including the Eu-
ropean Union (EU), and more than 180 non-
member economies. NIOSH is also work-
ing with the UN World Health Organization 
(WHO); the UN International Labour Orga-
nization (ILO); the International Organiza-
tion for Standardization (ISO); the Interna-
tional Electrotechnical Commission (IEC), the 
International Commission on Occupational 
Health (ICOH); and the International Coun-
cil on Nanotechnology (ICON) on global proj-
ects of information dissemination and commu-
nication.
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8 OUTCOMES
Nanotechnology is a rapidly developing area of 
science and technology that promises great ben-
efits. To realize these benefits, it is important to 
protect workers potentially exposed to ENMs 
in nanomaterial research, production, and use 
[Schulte and Salamanca-Buentello 2007; Nas-
terlack et al. 2008; Howard and Murashov 
2009]. The NIOSH NTRC strategic plan is de-
signed to identify and create the information 
needed for risk management programs that will 
control and prevent negative impacts on work-
er health. Outcomes of the NIOSH NTRC re-
search will be translated into products that can 
be used by the nanotechnology community to 
develop and implement appropriate risk man-
agement practices to minimize worker exposure 
to ENMs. NIOSH also will evaluate how re-
search results and risk management guidance 
developed by NIOSH influence others to take 
action to prevent exposure to hazards related to 
ENMs. 
NIOSH will assess the extent to which its re-
search efforts have addressed each element of 
the risk management process (illustrated in Fig-
ure 6) and determine how the outcomes of re-
search have influenced others to take action to 
prevent exposure to hazards related to ENMs. 
NIOSH will publish a report of its research 
outcomes for the 2013–2016 period. A summa-
ry of proposed research for FY2013–2014 and 
FY2015–2016 is shown in Appendix B
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Appendix A
Comprehensive Chart of the NNI 2011 
EHS Research Needs
[National Nanotechnology Initiative: Environmental, Health, and Safety Research Strategy. 
Washington, DC: United States Executive Office of the President, Office of Science and Tech-
nology Policy, Nanotechnology Environmental and Health Implications (NEHI) Working 
Group, Table D–1.] 
Protecting the Nanotechnology Workforce   |   4140   |   Protecting the Nanotechnology Workforce
Key Research Needs Subordinate Research Needs
1. Nanomaterial Measurement Infrastructure Research Needs
Develop measurement tools to detect and identify engineered nanoscale materials in products and rele-
vant matrices and determine their physico-chemical properties throughout all stages of their life cycles.
Develop measurement tools for determination of biological response and to enable assessment of hazards 
and exposure for humans and the environment from engineered nanomaterials and nanotechnology-based 
products throughout all stages of their life cycles.
RN#1. Develop measurement 
tools for determination of 
physico-chemical properties of 
ENMs in relevant media and 
during the life cycles of ENMs 
and NEPs
 • Physical dimensions and morphology: size, size distribution, char-
acteristic dimensions, shape
 • Internal structure: atomic-molecular, core-shell
 • Surface and interfacial properties: surface charge, zeta potential, 
surface structure, elemental composition, surface-bound molecular 
coatings and conjugates, reactivity
 • Bulk composition: elemental or molecular composition, crystalline 
phase(s)
 • Dispersion properties: degree and state of dispersion
 • Mobility and other transport properties: diffusivity, transport in 
biological and environmental matrices
RN#2. Develop measurement 
tools for detection and moni-
toring of ENMs in realistic ex-
posure media and conditions 
during the life cycles of ENMs 
and NEPs
 • Sampling and collection of ENMs
 • Detecting the presence of ENMs
 • Quantity of ENMs-concentration based on surface area, mass, and 
number concentrations
 • Size and size distribution of ENMs
 • Spatial distribution of ENMs
 • Discriminating ENMs from ambient NMs such as combustion 
products and welding fumes
 • Discriminating multiple types of ENMs such as metals and metal 
oxides
RN#3. Develop measurement 
tools for evaluation of transfor-
mations of ENMs in relevant 
media and during the life cy-
cles of ENMs and NEPs
 • Agglomeration and de-agglomeration
 • Dissolution and solubility
 • Absorption of natural organic matter and bioconstituents
 • Oxidation and reduction
 • Deposition of ENMs on surfaces
(continued)
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RN#4. Develop measurement 
tools for evaluation of biolog-
ical responses to ENMs and 
NEPs in relevant media and 
during the life cycles of ENMs 
and NEPs
 • Adequacy of existing assays
 • New assays or high-throughput, high content assays
 • Correlation of biological responses with physico-chemical 
properties
 • Surface reactivity at the interfaces between ENMs and biological 
receptors
 • Biomarkers of toxicological response
RN#5. Develop measurement 
tools for evaluation of release 
mechanisms of ENMs from 
NEPs in relevant media and 
during the life cycles of NEPs
 • Release by fire, combustion, and incineration
 • Release by mechanical degradation, such as abrasion, deformation, 
and impact
 • Release by dissolution of matrix material
 • Release by chemical reactions of the matrix material
 • Release by photo-induced degradation of the matrix material
 • Release by consumer interactions, such as spraying, mouthing, and 
swallowing
 • Release by interactions with biological organisms in the envi-
ronment
2. Human Exposure Assessment Research Needs
Identify potential sources, characterize the exposure scenarios, and quantify actual exposures of workers, 
the general public and consumers to nanomaterials.
Characterize and identify the health outcomes among exposed populations in conjunction with informa-
tion about the control strategies used and exposures to determine practices that result in safe levels of ex-
posure.
RN#1. Understand processes 
and factors that determine ex-
posures to nanomaterials
 • Conduct studies to understand processes and factors that deter-
mine exposure to engineered nanomaterials
 • Develop exposure classifications of nanomaterials and processes
 • Develop internationally harmonized and validated protocols for 
exposure surveys, sample collection and analysis, and reporting 
through existing and newly created international frameworks
 • Develop comprehension predictive models for exposures to a 
broad range of engineered nanomaterials and processes
 • Characterize process- and task-specific exposure scenarios in the 
workplace
(continued)
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RN#2. Identify population 
groups exposed to engineered 
nanomaterials
 • Systematically collect and analyze information about nanomate-
rial manufacture, processing, and direct use in commercial and 
consumer products over time to discern geographic areas where 
engineered nanomaterials may be emitted into the environment, 
consumed in the form of ingredients of products, and/or disposed 
of in solid waste, wastewater, etc.
 • Conduct population-based surveys to obtain information on use 
patterns for consumer products
 • Identify potential subpopulations that are more susceptible to 
exposure to engineered nanomaterials than others
 • Develop quantitative assessment methods appropriate for target 
population groups and conduct assessments of those population 
groups most likely to be exposed to engineered nanomaterials
RN#3. Characterize individual 
exposures to nanomaterials
 • Expand currently available exposure assessment techniques to 
facilitate more accurate exposure assessment for engineered 
nanomaterials at benchmark concentration levels using feasible 
methods
 • Develop new tools through national and international surveys to 
support effective exposure characterization of individuals
 • Characterize and detect nanomaterials in biological matrices and 
conduct studies to understand transformations of nanomaterials 
during transport in the environment and in human bodies
 • Conduct studies to examine emissions and human contact during 
normal use and after wear and tear have degraded a product, as 
well as during repeated exposures
 • Develop engineered nanomaterials exposure assessment models 
based on identified critical exposure descriptions
 • Develop databases to contain the collected data and information
RN#4. Conduct health sur-
veillance of exposed popula-
tions
 • Establish a program for the epidemiological investigations of 
physician case reports and reports of suspicious pattern of adverse 
events
 • Establish exposure registry and medical surveillance programs for 
workers
 • Analyze injury and illness reporting in existing programs
(continued)
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3. Human Health Research Needs
Understand the relationship of physico-chemical properties of engineered nanoscale materials to in vivo 
physico-chemical properties and biological response.
Develop high-confidence predictive models of in vivo biological responses and casual physico-chemical 
properties of ENMs.
RN#1. Identify or develop ap-
propriate, reliable, and repro-
ducible in vitro and in vivo 
assays and models to predict 
in vivo human responses to 
ENMs
 • Establish a system to develop and apply reliable and reproducible 
in vitro and in vivo test  methods
 • Evaluate the degree to which an in vitro response correlates with 
an in vivo response
 • Evaluate the degree to which in vitro and in vivo models predict 
human response
 • Translate structure-activity relationship and other research data 
into computational models to predict toxicity in silico
RN#2. Quantify and charac-
terize ENMs in exposure ma-
trices and biological matrices
 • Determine critical ENM measurands in biological and environ-
mental matrices and ensure the development of tools to measure 
ENMs in appropriate matrices as needed
 • Determine matrix and/or weathering effects that may alter the 
physico-chemical characteristics of the ENM measurands
 • Identify key factors that may influence the detection of each mea-
surand in a particular matrix (e.g., sample preparation, detection 
method, storage, temperature, solvents/solutions)
 • Characterize and quantify exposure for all exposure routes using in 
vivo models to identify the most likely routes of human exposure
 • Identify biomarkers of exposure and analytical methods for their 
determination
RN#3. Understand the rela-
tionship between the physico-
chemical properties of ENMs 
and their transport, distribu-
tion, metabolism, excretion, 
and body burden in the hu-
man body
 • Characterize ENM physico-chemical properties and link to 
mechanisms of transport and distribution in the human body
 • Understand the relationship of the physico-chemical properties of 
ENMs to the mechanisms of sequestration in and translocation of 
ENMs out of the exposure organ and secondary organs, and to routes 
of excretion from the human body
 • Determine the metabolism or biological transformation of ENMs 
in the human body
(continued)
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RN#4. Understand the rela-
tionship between the physico-
chemical properties of ENMs 
and uptake through the human 
port-of-entry tissues
 • Characterize ENMs at and in port-of-entry tissues, including 
nontraditional routes of entry such as the ear and eye, and identify 
mechanisms of ENM uptake into tissues
 • Determine the relationship of ENM physico-chemical properties 
to deposition and uptake under acute exposure conditions and 
under chronic exposure conditions
 • Translate data on ENM properties and uptake to knowledge that 
may be used to intentionally redesign ENMs for optimum human 
and environmental safety and product efficacy
RN#5. Determine the modes 
of action underlying the human 
biological response to ENMs 
at the molecular, cellular, tissue, 
organ, and whole body levels
 • Determine the dose response and time course of biological 
responses at the primary site of exposure and at distal organs fol-
lowing ENM exposure
 • Understand the mechanisms and molecular pathway(s) associated 
with ENM biology within cellular, organ, and whole organism 
systems
 • Link mechanisms of response with ENM physico-chemical prop-
erties and employ this information in the design and development 
of future ENMs
 • Develop translational alternative in vitro testing methods for 
the rapid screening of future ENMs based on mechanism(s) of 
response that are predictive of in vivo biological responses
RN#6. Determine the extent 
to which life stage and/or sus-
ceptibility factors modulate 
health effects associated with 
exposure to ENMs and nan-
otechnology-enabled products 
and applications
 • Determine the effect of life stage and/or gender on biological 
response to ENMs
 • Establish the role of genetic and epigenetic susceptibility on the 
biological response to ENMs in the context of life stage and/or 
susceptibility factors
 • Understand mechanistically the influence of preexisting disease on 
the biological response to ENMs in the context of life stage and 
other susceptibility factors
 • Identify exposure conditions that make susceptible individuals 
more vulnerable to the health effects associated with ENMs and 
nanotechnology-enabled applications
 • Establish a database that contains published, peer-reviewed litera-
ture, occupational and consumer reports, and toxicological profiles 
that describe altered responses to ENMs and nanotechnology-
enabled applications in susceptible animal models or individuals 
following exposure
(continued)
Table D–1 (Continued). The Core EHS Research Categories and their Highest-Priority Research Needs (RNs)
Protecting the Nanotechnology Workforce   |   4544   |   Protecting the Nanotechnology Workforce
Key Research Needs Subordinate Research Needs
4. Environment Research Needs
Understand the environmental fate, exposure, and ecological effects of engineered nanomaterials, with 
priority placed on materials with highest potential for release, exposure, and/or hazard to the environ-
ment.
RN#1. Understand environ-
mental exposures through 
the identification of principal 
sources of exposure and expo-
sure routes
 • Manufacturing processes and product incorporation
 • Life cycle of technology and exposures subsequent to product 
manufacturing
 • Analytical approaches to measure temporal changes in nanopar-
ticle properties throughout the life cycle
 • Models to estimate releases
 • Environmental receptors for exposure assessment
RN#2. Determine factors af-
fecting the environmental 
transport of nanomaterials
 • Determine key physico-chemical properties affecting transport
 • Determine key transport and fate processes relevant to environ-
mental media
 • Develop new tools and adaptation of current predictive tools to 
accommodate unique properties of nanomaterials
RN#3. Understand the trans-
formation of nanomaterials 
under different environmental 
conditions
 • Identify and evaluate nanomaterial properties and transformation 
processes that will reduce environmental persistence, toxicity, and 
production of toxic products
 • Determine the rate of aggregation and long-term stability of 
agglomeration/aggregation and the long-term stability of these 
aggregates and agglomerates
 • Develop tools to predict the transformations or degradability of 
nanomaterials
RN#4. Understand the effects 
of engineered nanomaterials on 
individuals of a species and the 
applicability of testing schemes 
to measure effects
 • Test protocols
 • Dose-response characterization
 • Uptake/elimination kinetics, tissue/organ distribution
 • Mode/mechanism of action, predictive tools
 • Tiered testing schemes/environmental realism
RN#5. Evaluate the effects of 
engineered nanomaterials at 
the population, community, 
and ecosystem levels
 • Population
 • Community
 • Other ecosystem-level effects
 • Predictive tools for population-, community-, and ecosystem-level 
effects
(continued)
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5. Risk Assessment and Risk Management Methods Research Needs
Increase available information for better decision making in assessing and managing risks from nanoma-
terials, including using comparative risk assessment and decision analysis; life cycle considerations; and 
additional perspectives such as ELSI considerations, stakeholders’ values, and additional decision makers’ 
considerations.
RN#1. Incorporate relevant 
risk characterization informa-
tion, hazard identification, ex-
posure science, and risk mod-
eling and methods into the 
safety evaluation of nanoma-
terials
 • Characterization, fate, and release of nanoparticles throughout the 
life cycles of nanotechnology-enabled products
 • Development of predictive models on accumulation, migration, 
and release of nanoparticles throughout the life cycles of nano-
technology-enabled products
 • Safety of nanoparticles throughout the life cycles of the nanotech-
nology-enabled products
 • Comprehensive and predictive models to assess the potential risks 
of nanoparticles during the manufacturing and life cycle of nano-
products, with inputs from human and environment exposures 
and on nanomaterial properties
RN#2. Understand, character-
ize, and control workplace ex-
posures to nanomaterials
 • Dissemination and implementation of effective techniques and 
protocols to measure exposures in the workplace
 • Identification and demonstration of effective containment and 
control technologies including for accidents and spills
 • Development of an effective industry surveillance system
 • Design and deployment of a prospective epidemiological frame-
work relevant to exposure science
 • Systematic approaches for occupational risk modeling
RN#3. Integrate life cycle con-
siderations into risk assessment
 • Establishment of nanotechnology-specific taxonomy for life cycle 
stages
 • Integration of risk assessment, life cycle analyses, and decision-
making approaches into regulatory decision making processes
 • Application of adaptive management tools based on monitoring/
implementation to evaluate life cycle analysis implementation
 • Development of case studies, e.g., green chemistry, nanomaterials 
selection, nanomaterials acquisition process, illustrating applica-
tion of these risk management methods
(continued)
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RN#4. Integrate risk assess-
ment into decision-making 
frameworks for risk manage-
ment
 • Development of comparative risk assessment and formal decision-
analytical methods as opposed to “absolute” risk assessment strate-
gies
 • Application of formal decision-analytical methods to prioritize 
risk management alternatives
 • Use of gap analyses and value of information analysis to identify 
research needs
 • Integration of stakeholder values and risk perceptions into risk 
management processes
 • Application of integrated decision framework through case studies 
in risk management decision making
RN#5. Integrate and standard-
ize risk communication with-
in the risk management frame-
work
 • Development and use of standardized terminology in risk 
communications
 • Early information-sharing on hazards and risk among Federal 
agencies
 • Development of appropriate risk communication approaches for 
agency-specific needs
Informatics and Modeling Research Need
RN#1. Develop computation-
al models of ENM structure- 
property-activity relationships 
to support the design and de-
velopment of ENM with max-
imum benefit and minimum 
risk to humans and the envi-
ronment
 • Validate the predictive capability of in vitro and in vivo assays 
and employ that subset of assays in data generation to establish 
computational models to predict ENM behavior in humans and 
the environment
 • Establish a standard set of physical and chemical characterization 
parameters, dose metrics, and biological response metrics
 • Design and establish structures and ontologies for methods devel-
opment, data capture, sharing, and analysis
 • Evaluate and adapt as necessary existing computational models by 
beginning with existing models for exposure and dosimetry and 
using data generated from validated assays
 • Use ENM exposure and dosimetry models to develop ENM 
structure-activity models to predict ENM behavior in humans 
and the environment
 • Establish training sets and beta test sites to refine and validate 
ENM structure-activity models
 • Disseminate ENM structure-activity models through publicly ac-
cessible nanotechnology websites
Table D–1 (Continued). The Core EHS Research Categories and their Highest-Priority Research Needs (RNs)
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APPENDIX B 
Timeline for NIOSH Nanotechnology Research 
Summary of Proposed Research Projects, FY2013–FY2014
Critical research area Projects
Toxicity and 
Internal Dose
Evaluate long-term fibrogenic and carcinogenic potential of carbon nano-
tubes and carbon nanofibers.
Determine immune and cardiovascular responses to pulmonary exposure 
to CNT, TiO2, and nanosilver.
Evaluate the pulmonary effects of nanosilver.
Measurement Methods Develop updated methods and approaches to assess occupational expo-
sures to nanomaterials.
Utilize reference materials and technically sound protocols to improve 
measurement quality.
Develop techniques to characterize nanoparticles, using advanced micros-
copy methods.
Study the performance of direct reading instruments for assessing emis-
sions and exposure to nanoparticles in the workplace.
Exposure Assessment Complete evaluation of workplace exposures to emerging, second-
generation, and third-generation ENMs and their potential routes 
of exposure.
Complete evaluation of size, concentration, and morphology of ENMs 
emitted by various processes.
Epidemiology and 
Surveillance
Evaluate occupational exposures among carbonaceous 
nanomaterial workers.
Complete field work for a cross-sectional epidemiologic survey among 
workers exposed to carbonaceous nanomaterials.
Collect data on specific biomarkers as markers of exposure or early health 
endpoints in workers exposed to carbon nanotubes or carbon nanofibers.
(continued)
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Critical research area Projects
Risk Assessment Develop a strategy and criteria to utilize the best available scientific data 
to develop hazard- and risk-based occupational exposure limits and other 
risk management guidance.
Identify nanomaterial categories by physicochemical properties and bio-
logical mode of action, and perform case study evaluations for nanomate-
rials within each major category.
Analyze toxicity data, including identifying the adverse health 
endpoint(s) and performing dose-response analyses and/or comparative 
potency analyses.
Contribute to the development and evaluation of dosimetry models and 
methods to assess internal dose of nanomaterials in workers.
Engineering Controls 
and PPE
Conduct field studies to assess and improve engineering control strategies 
in the workplace.
Evaluate effectiveness of commercially available engineering controls in 
the laboratory.
Finalize development of a standardized aerosol test method using mag-
netic passive aerosol samplers for testing of protective clothing material. 
Expand particulate penetration project to include evaluation of different 
types of fabrics, use of electrostatic charges, and bellows effects.
Evaluate balance between comfort and protection of protective clothing 
and gloves with ENMs.
Fire and Explosion Safety Evaluate nano metals and other ENMs for fire and explosion potential.
Evaluate a variety of ENMs for electromagnetic hazard potential.
Correlate dustiness of ENMs with various physical and chemical 
safety hazards.
Evaluate current DOT and NFPA guidance for adequacy with ENMs.
Provide recommendations to first responders about safety issues 
of ENMs.
Recommendations 
and Guidance
Continue conducting r2p activities (ongoing), such as developing bro-
chures and fact sheets and updating the topic page. 
Develop a small business guide for nanomaterial producers and users.
Summary of Proposed Research Projects, FY2013–FY2014
(continued)
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Critical research area Projects
Applications Further develop and refine end-of-service indicators using nanomaterials.
Global Activities Strengthen participation with globally recognized organizations ICON, 
ISO, OECD, and UN (WHO, ILO).
Participate in the US/EU nanomaterial working groups hosted by the 
NNI.
Summary of Proposed Research Projects, FY2013–FY2014
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Summary of Proposed Research Projects for FY2015–FY2016
Critical research area Projects
Toxicity and Internal Dose Identify biomarkers of response to ENMs.
Develop predictive algorithms for relationships between nanoparticle 
properties and bioactivity.
Determine the relevance of in vitro and in vivo screening tests.
Evaluate the pulmonary and systemic effects of graphene and nanocellu-
lose.
Measurement Methods Publish updated exposure measurement methods.
Assist with round-robin evaluations of ENM reference materials.
Exposure Assessment Publish exposure results.
Provide guidance on exposure assessment methods and sampling proto-
cols.
Epidemiology and 
Surveillance
Analyze biomarker samples from cross-sectional epidemiologic study of 
carbon nanotube and nanofiber workers.
Analyze data (medical and biomarker with exposure) from cross-sectional 
epidemiologic study of carbon nanotube and nanofiber workers.
Begin collecting data for exposure registry and prospective epidemiolog-
ic study among carbon nanotube–exposed and carbon nanofiber–exposed 
workers.
Assess feasibility of epidemiologic study of health outcomes among work-
ers exposed to nanomaterials other than carbonaceous nanomaterials.
Risk Assessment Extend evaluations of the hazard and risk of workplace exposure to new 
nanomaterials.
Utilize the latest data from toxicity studies, workplace exposure measure-
ments, and/or biomonitoring data to identify potential hazards in the re-
spiratory tract and/or other organs.
Contribute to the refinement and validation of dosimetry models for 
nanomaterials. 
Contribute to the evaluation and development or updating of recom-
mended exposure limits and other risk management guidance.
(continued)
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Critical research area Projects
Engineering Controls 
and PPE
Continue to assess engineering controls in the field and update recom-
mendations for controlling exposure.
Continue to evaluate commercially available engineering controls in the 
lab and publish test results.
Evaluate respirator performance with ENMs in laboratory and workplace 
settings.
Develop a passive method for measuring particle penetration through 
protective clothing materials.
Fire & Explosion Safety Continue evaluation of various ENMs for fire and explosion potential.
Evaluate a variety of ENMs for electromagnetic hazard potential.
Correlate dustiness of ENMs with various physical and chemical safety 
hazards. 
Publish findings in journals and provide summaries to DOT and NFPA. 
Recommendations and 
Guidance
Update Approaches to Safe Nanotechnology
Develop hazard bands and RELs for high-volume commercially available 
ENMs.
Applications Evaluate ENM-enabled PPE.
Global Activities  Lead or co-lead committees with globally recognized organizations: 
ICON, ISO, OECD, and UN (WHO, ILO).
NOTE: DOT, Department of Transportation; ENMs, engineered nanomaterials; ICON, International Council on 
Nanotechnology; ILO, International Labour Organization; ISO, International Organization for Standardization; 
NFPA, National Fire Protection Association; NNI, National Nanotechnology Initiative; OECD, Organization for 
Economic Cooperation and Development; PPE, personal protective equipment; UN, United Nations; WHO, World 
Health Organization.
Summary of Proposed Research Projects for FY2015–FY2016 (Continued)
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To receive NIOSH documents or more information about 
occupational safety and health topics, contact NIOSH at
1–800–CDC–INFO (1–800–232–4636) 
TTY: 1–888–232–6348 
CDC INFO: www.cdc.gov/info
or visit the NIOSH website at www.cdc.gov/niosh.
For a monthly update on news at NIOSH, subscribe to NIOSH 
eNews by visiting www.cdc.gov/niosh/eNews.
DHHS (NIOSH) Publication No. 2014–106
safer • healthier • people™
Delivering on the Nation’s promise: 
safety and health at work for all people 
through research and prevention
